← Open Payments lookup

CAROLYN PETERS: Open Payments

NPI 1619363306 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$601 in 19 payments from 13 companies in 2025. Trend: 2023 $210 · 2024 $1,046 · 2025 $601

Food & beverage: $518Education: $83
CompanyPaymentsAmount
BeiGene USA, Inc.1$122
SANOFI-AVENTIS U.S. LLC1$83
Daiichi Sankyo Inc.3$76
Merck Sharp & Dohme LLC2$58
Aveo Pharmaceuticals, Inc.1$45
Novartis Pharmaceuticals Corporation2$43
Celgene Corporation2$43
GENZYME CORPORATION2$40
Janssen Biotech, Inc.1$26
Ipsen Biopharmaceuticals, Inc1$18

Products named: BRUKINSA, SARCLISA, FOTIVDA, REBLOZYL, LYNPARZA, Vanflyta, KISQALI, Enhertu.

Industry payments across TX — which companies pay providers there.